Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.
about
Immunotherapy as treatment for Alzheimer’s diseaseAlzheimer's therapeutics: translation of preclinical science to clinical drug developmentAmyloid-β peptide-specific DARPins as a novel class of potential therapeutics for Alzheimer diseaseChronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice.Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 mice.Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice.Nasal mucosal inhalation of amyloid-beta peptide 3-10 defective adenovirus attenuates cytotoxicity induced by beta-amyloid (1-42).Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer's disease transgenic mouse modelUsing mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse modelsOral administration of a fusion protein between the cholera toxin B subunit and the 42-amino acid isoform of amyloid-β peptide produced in silkworm pupae protects against Alzheimer's disease in mice.Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.Emerging therapeutics for Alzheimer's disease: an avenue of hope.Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury.Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity.Neurologic and motor dysfunctions in APP transgenic mice.Three weeks of running wheel exposure improves cognitive performance in the aged Tg2576 mouseComprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's diseaseIntermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition.The impact of flavonoids on spatial memory in rodents: from behaviour to underlying hippocampal mechanismsImmunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice.Mouse models of Alzheimer's disease.N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders.Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.Comment on Vicki Brower's article 'Harnessing the immune system to battle Alzheimer's' in EMBO reports, March 2002.Use of magnetization transfer contrast MRI to detect early molecular pathology in Alzheimer's disease.Biomarkers for Alzheimer's Disease Diagnosis.Active immunization of mice with an Abeta-Hsp70 vaccine.Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.A case for a non-transgenic animal model of Alzheimer's disease.Prevention of pathological change and cognitive degeneration of Tg2576 mice by inoculating Abeta(1-15) vaccine.EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment.
P2860
Q22241491-16B8486B-9A8B-44D6-8726-E1B19CA0F597Q26829267-3922AAC4-CD61-466F-888C-41FC7B5E858EQ28655482-7C86FC45-5602-4C9C-81CC-9E0C6711625BQ33291589-E78517D5-ADF1-4AC5-B50E-DC1630730F71Q33731666-9FE0A016-FCD2-4B07-8766-DB30E5F3A248Q33926265-541EFD70-5241-4BDD-8DCA-511F9585A0B4Q34096147-3DF5FA0B-9FDC-41F6-86BF-C421EB24F291Q34345499-7E8E6741-89C2-4531-A349-B3AAB6D6F29BQ34418781-3D9627CC-6897-46E1-81F0-D1C3D549D3B1Q34624985-5BEDBAF5-B776-4131-88ED-E74C9943D720Q34985230-859E0205-DF43-4E30-8445-38A34AB5DE58Q35618922-4545A743-68C6-4B5D-8912-E6CC06D625F6Q35878754-EE5631E6-3C42-4FCD-8C20-5E66D9F2FA60Q36155197-CA58964F-8DEC-452A-8E40-398676A09901Q36347389-53C7ED45-EDD7-440B-BF0B-B717D72E8A8DQ36409258-32C98723-EFAA-4D90-98D5-8A3294C497FFQ36997908-797C9B27-C402-4FEB-B444-EC773059C986Q37144657-A91CC447-4196-40A4-841B-622D0BA08A71Q37418038-240F0C8A-2BBE-48AE-8DDA-1E98ED81B636Q37504954-1A8552AC-0D9C-4D4F-9A3E-E37E87C1DF70Q37964886-097399F6-BA20-4696-A5BC-9BA9015EBA99Q40113255-097E808F-1D61-4B87-A530-E9D2A46C216BQ42013048-E321B6FA-679E-4D99-891D-AA97B4C1EAC0Q42724497-56939E65-542D-4695-88C3-6865BC6603D4Q44260204-DFD76DB0-AB54-4DD5-996A-4F13F4171B9EQ46872931-EA114F4F-3A8C-4C2F-85CB-D0C99A1DEB04Q48447189-2939C8F5-03BC-4248-8227-173301EBB0A5Q48464419-15632C16-B8C5-4733-9D08-7FDB7045FF66Q48943001-ED3F4BBE-854F-4FA4-AFA2-F31AE9559D73Q49014095-25930E35-5A15-4EBA-A81B-06D6BB066BDCQ55255033-7F86A664-C4D9-4467-AFF3-A8EFC292134B
P2860
Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Behavioral assessment of Alzhe ...... deposition and spatial memory.
@en
Behavioral assessment of Alzhe ...... deposition and spatial memory.
@nl
type
label
Behavioral assessment of Alzhe ...... deposition and spatial memory.
@en
Behavioral assessment of Alzhe ...... deposition and spatial memory.
@nl
prefLabel
Behavioral assessment of Alzhe ...... deposition and spatial memory.
@en
Behavioral assessment of Alzhe ...... deposition and spatial memory.
@nl
P2093
P1433
P1476
Behavioral assessment of Alzhe ...... deposition and spatial memory.
@en
P2093
Arendash GW
Diamond DM
Hatcher JM
P304
P356
10.1089/10445490152717604
P577
2001-11-01T00:00:00Z